{"id":"W2402016156","doi":"10.1158/1535-7163.targ-15-b194","title":"Abstract B194: Tivantinib in combination with erlotinib vs erlotinib alone for EGFR mutant NSCLC: Subgroup results from the phase 3 MARQUEE study","year":2015,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Erlotinib; Cancer; Medicine; Oncology; Pharmacology; Internal medicine; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003670922,0.001354144,0.002927804,0.000388004,0.0003836535,0.001919633,0.001016848,0.001241033,0.005814185],"category_scores_gemma":[0.003020441,0.0005055984,0.005338157,0.0005081083,0.0004237056,0.001069601,0.0004466588,0.003499853,0.0015358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009032626,"about_ca_system_score_gemma":0.001106461,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00109386,"about_ca_topic_score_gemma":0.003605281,"domain_scores_codex":[0.9987413,0.0007493095,0.00008470824,0.0001281447,0.0001586393,0.0001379748],"domain_scores_gemma":[0.9987512,0.0003753691,0.0002871186,0.0001511333,0.0001212291,0.000313997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8976781,0.004375089,0.007006214,0.001286188,0.01558682,0.0001999376,0.0001321545,0.001196466,0.009861672,0.0002811834,0.01348842,0.04890779],"study_design_scores_gemma":[0.7477081,0.1545654,0.05219355,0.000339959,0.02076958,0.000446192,0.0002074484,0.001905451,0.003156843,0.0009931982,0.01756612,0.0001481192],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9242507,0.04555631,0.001159162,0.003687994,0.001189878,0.003540662,0.01089005,0.0001531704,0.009572175],"genre_scores_gemma":[0.9668559,0.008751941,0.001396418,0.002323155,0.001315636,0.002214383,0.0107964,0.00009136501,0.006254661],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005814185,"threshold_uncertainty_score":0.01945043,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04897850486155135,"score_gpt":0.3676255073323042,"score_spread":0.3186470024707528,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}